Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -8.46%822M | -3.28%1.74B | 2.04%898M | 0.58%1.79B | -1.91%880.01M | -33.10%1.78B | -32.29%897.13M | 54.12%2.67B | 78.81%1.32B | 37.11%1.73B |
| Operating income | -8.46%822M | -3.28%1.74B | 2.04%898M | 0.58%1.79B | -1.91%880.01M | -33.10%1.78B | -32.29%897.13M | 54.12%2.67B | 78.81%1.32B | 37.11%1.73B |
| Cost of sales | 3.81%-618.11M | 1.67%-1.29B | -1.24%-642.57M | -0.01%-1.31B | 5.70%-634.69M | 30.08%-1.31B | 24.60%-673.08M | -56.14%-1.88B | -82.00%-892.7M | -36.11%-1.2B |
| Operating expenses | 3.81%-618.11M | 1.67%-1.29B | -1.24%-642.57M | -0.01%-1.31B | 5.70%-634.69M | 30.08%-1.31B | 24.60%-673.08M | -56.14%-1.88B | -82.00%-892.7M | -36.11%-1.2B |
| Gross profit | -20.17%203.9M | -7.66%444.49M | 4.12%255.43M | 2.17%481.35M | 9.49%245.32M | -40.28%471.11M | -48.17%224.05M | 49.51%788.9M | 72.56%432.27M | 39.44%527.64M |
| Selling expenses | -16.85%-5.23M | 13.79%-10.85M | 14.63%-4.48M | -21.12%-12.59M | 7.29%-5.24M | 21.51%-10.4M | -16.41%-5.65M | -54.08%-13.24M | -46.43%-4.86M | 6.29%-8.6M |
| Administrative expenses | 13.05%-77.62M | 9.80%-171.25M | 9.98%-89.26M | 17.22%-189.86M | 17.55%-99.16M | 6.52%-229.37M | -6.36%-120.26M | -32.42%-245.36M | -25.08%-113.07M | -18.89%-185.29M |
| Impairment and provision | 17.17%-48.05M | 83.30%-116.65M | 77.97%-58.01M | -457.19%-698.56M | -583.43%-263.36M | 11.98%-125.37M | -859.78%-38.54M | -1,196.57%-142.44M | 44.37%-4.02M | -127.41%-10.99M |
| -Other impairment is provision | 17.17%-48.05M | 83.30%-116.65M | 77.97%-58.01M | -457.19%-698.56M | -583.43%-263.36M | 11.98%-125.37M | -859.78%-38.54M | -1,196.57%-142.44M | 44.37%-4.02M | -127.41%-10.99M |
| Special items of operating profit | -302.85%-1.64M | -1,797.84%-7.02M | -80.69%808K | -101.52%-370K | -51.15%4.19M | 398.79%24.39M | 148.46%8.57M | 166.78%4.89M | -57.06%3.45M | -1,341.19%-7.32M |
| Operating profit | -31.71%71.36M | 133.02%138.71M | 188.36%104.49M | -422.20%-420.03M | -273.48%-118.26M | -66.81%130.37M | -78.28%68.17M | 24.51%392.75M | 99.09%313.78M | 50.82%315.44M |
| Financing income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 3.38%703K | -62.19%1.22M |
| Financing cost | 67.19%-63K | 51.56%-326K | -7.26%-192K | 12.60%-673K | 54.34%-179K | -437.72%-770K | ---392K | --228K | ---- | ---- |
| Share of profits of associates | 38.78%5.31M | 162.81%16.57M | 5.37%3.83M | -40.11%6.31M | -56.73%3.63M | -44.13%10.53M | 190.72%8.4M | 2,692.00%18.85M | 355.68%2.89M | --675K |
| Special items of earning before tax | 92.98%-3M | 31.82%-114.2M | -183.22%-42.71M | -13,685.60%-167.5M | -3,406.74%-15.08M | 99.56%-1.22M | 98.29%-430K | -5,719.39%-276.77M | -1,152.97%-25.21M | -127.67%-4.76M |
| Earning before tax | 12.52%73.61M | 107.00%40.76M | 150.37%65.42M | -518.90%-581.9M | -271.47%-129.88M | 2.86%138.91M | -74.07%75.74M | -56.80%135.05M | 81.12%292.17M | 48.64%312.58M |
| Tax | -37.43%-20.22M | -110.53%-15.19M | -144.66%-14.71M | 546.58%144.31M | 268.44%32.95M | 51.72%-32.32M | 74.16%-19.56M | 19.42%-66.93M | -98.54%-75.7M | -92.16%-83.06M |
| After-tax profit from continuing operations | 5.30%53.39M | 105.84%25.56M | 152.31%50.7M | -510.51%-437.58M | -272.53%-96.93M | 56.48%106.6M | -74.05%56.18M | -70.32%68.12M | 75.72%216.46M | 37.38%229.53M |
| Earning after tax | 5.30%53.39M | 105.84%25.56M | 152.31%50.7M | -510.51%-437.58M | -272.53%-96.93M | 56.48%106.6M | -74.05%56.18M | -70.32%68.12M | 75.72%216.46M | 37.38%229.53M |
| Minority profit | -12.43%5.57M | -11.40%10.99M | 41.92%6.36M | -6.13%12.4M | -39.21%4.48M | 16.75%13.21M | 0.31%7.37M | 49.39%11.32M | 79.59%7.35M | 138.85%7.57M |
| Profit attributable to shareholders | 7.84%47.82M | 103.24%14.58M | 143.73%44.35M | -581.86%-449.98M | -307.76%-101.41M | 64.39%93.39M | -76.66%48.81M | -74.41%56.81M | 75.59%209.12M | 35.42%221.95M |
| Basic earnings per share | 6.90%0.31 | 103.08%0.09 | 143.94%0.29 | -578.69%-2.92 | -306.25%-0.66 | 64.86%0.61 | -76.47%0.32 | -75.50%0.37 | 60.00%1.36 | 29.06%1.51 |
| Diluted earnings per share | 6.90%0.31 | 103.08%0.09 | 143.94%0.29 | -578.69%-2.92 | -306.25%-0.66 | 69.44%0.61 | -76.12%0.32 | -75.68%0.36 | 61.45%1.34 | 26.50%1.48 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | CCA Zhonghuan (Hong Kong) Fushin Certified Public Accountants Limited | -- | Kaiyuan Shun Tak Certified Public Accountants Limited | -- | Kaiyuan Shun Tak Certified Public Accountants Limited | -- | Kaiyuan Shun Tak Certified Public Accountants Limited | -- | Grant Thornton (Hong Kong) Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.